ALKALOID ‐ DIHYDROGENATED ERGOT ALKALOIDS vs placebo
Tardive dyskinesia: Deterioration of symptoms · female and male 59‐80 (mean) years old patients with antipsychotic‐induced tardive dyskinesia
It is very uncertain whether ALKALOID ‐ DIHYDROGENATED ERGOT ALKALOIDS changes tardive dyskinesia: Deterioration of symptoms compared with PLACEBO (very low certainty).
1 finding from 1 review
- Miscellaneous treatments for antipsychotic‐induced tardive dyskinesia 2018 · Cochrane Headline outcomes onlyRR 0.33 [0.01, 7.55]1 study · 28 participantsVery low